Table 2 The epoch, MAE, MSE and MSLE of the optimal models in validation set.

From: Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema

Outcomes

Architectures

Epoch

MAE

MSE

MSLE

BCVA

CNN-MLP

97

0.094

0.017

0.010

CNN

29

0.136

0.027

0.015

CST

CNN-MLP

100

0.101

0.019

0.009

CNN

15

0.146

0.036

0.016

CV

CNN-MLP

98

0.053

0.005

0.002

CNN

71

0.058

0.007

0.003

CAT

CNN-MLP

96

0.063

0.011

0.005

CNN

10

0.098

0.016

0.006